Abstract
2-[18F] Fluoro-2-deoxy-D-glucose (FDG) is the most frequently used oncologic PET tracer and it has beenthestandard PET compound for more than ten years. The reason for this unequaled success lies in the coincidence of two main chemical concepts: a solid biochemical concept of the compound’s behavior with respect to the intercellular metabolism of carbohydrates, and the reliability of the nuclear chemical synthesis of this glucose tracer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson J, Foster AB, Hall LD, Johnson RN, Hesse RH (1970) Fluorinated carbohydrates. Carbohyd Res 15:351–359
Bida GT, Satyamurthy N, Barrio JR (1984) The synthesis of 2-[18F]Fluoro-2-deoxy-Dglucose using glycals: a reexamination. J Nucl Med 25:1327–1334
Blomqvist G, Bergstrom K, Bergstrom M, Elvin E, Eriksson L, Garmelius B, Lindberg B, Lilja A, Litton JE, Lundmark L, Lundqvist H, Malmberg P, Moström U, Nilsson L, Stone-Elander S, Widén L (1985) Models for 11C-glucose. In: Greitz T, Ingvar DH, Widén L (eds) The Metabolism of the Brain Studied with Positron Emission Tomography. Raven Press, New York, pp 185–194
Brendsted HE, Gjedde A (1988) Measuring brain glucose phosphoryla.tion with labeled glucose. Am J Physiol 254:E443–E448
Clark JC, Silvester DJ (1966) A cyclotron method for the production of fluorine-18. Int J Appl Radiat Isot 17:151–154
Conti PS, Liliern DL, Hawley K, Keppler J, Grafton ST, Bading JR (1996) PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 23:717–735
Cunningham VJ, Cremer JE (1981) A method for the simultaneous estimation of regional rates of glucose influx and phosphorylation in rat brain using radio-labelled 2-deoxy-glucose. Brain Res 221:319–330
Dubridge LA, Barnes SW, Buck JH (1937) Letters to the editor, proton induced radioactivity in oxygen. Phys Rev 51:995
European Pharmacopoeia 3rd Edition (1997) Radiopharmaceutical Preparations. pp 1424–1433
European Pharmacopoeia 3rd Edition, Supplement (1999). pp 515–518 (abstr)
Evans AC (1987) A double integral form of the three-compartmental, four-rate-constant model for faster generation of parameter maps. J Cereb Blood Flow Metab 7 (Suppl 1):5453
Füchtner F, Steinbach J, Mäding P, Johannsen B (1996) Basic hydrolysis of 2-[18F] fluoro-1,3,4,6-tetra-0-acetyl-D-glucose in the preparation of 2-[18F]Fluoro-2-deoxy-Dglucose. Appl Radiat Isot 47:61–66
Gaitonde MK (1965) Rate of utilization of glucose and `compartmentation’ of a-oxoglutarate and glutamate in rat brain. Biochem J 95:803–810
Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP (1978) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18-F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 19:11541161
Gatley SJ, Shaughnessy WJ (1982) Production of18F-labeled compounds with 18F-produced with a 1-MW research reactor. Int J Appl Radiat Isot 33:1325–1330
Gjedde A (1995) Glucose metabolism. In: Wagner HN, Szabo Z, Buchanan JW (eds) Principles of Nuclear Medicine, 2ndEdition. W. B. Saunders, Philadelphia
Hamacher K, Coenen HH, Stöcklin G (1986) Efficient stereospecific synthesis of no-carrier added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235–238
Hawkins R, Miller AL, Cremer JE, Veech RL (1974) Measurement of regional brain glucose utilization by rat brain in vivo. J Neurochem 23:917–923
Hawkins R, Hass K, Ransohoff J (1979) Measurement of regional brain glucose utilization in vivo using [2-14C]glucose. Stroke 10:690–703
Hawkins R, Mans AM, Davis DW, Vina JR, Hubbard LS (1985) Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position. Am J Physiol 248:C170–C176
Ido T, Wan CN, Casella V, Fowler JS, Wolf AP (1978) Labeled 2-deoxy-D-glucose analogs.18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and14C-2deoxy-2-fluoro-D-glucose. J Label Comp Radiopharm 14:175–183
Kuwabara H, Evans AC, Gjedde A (1990) Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F1 fluorodeoxyglucose. J Cereb Blood Flow Metab 10:180–189
Kuwabara H, Gjedde A (1991) Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med 32:692–698
Levy S, Elmaleh DR, Livni E (1982) A new method using anhydrous [18F]fluoride to radiolabel 2-[18F]fluoro-2-deoxy-D-glucose. J Nucl Med 23:918–922
Nickles RJ, Gatley SJ, Votaw JR, Kornguth ML (1986) Fluorine radiopharmaceuticals. Production of reactive fluorine-18. Appl Radiat Isot 37:649–661
Pacàk J, Tocik Z, Cerny M (1969) Synthesis of 2-deoxy-2-fluoro-D-glucose. Chem Comm 77
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with 2-[18F]fluoro-2deoxy-D-glucose: validation of method. Ann Neurol 6:371–388
Qaim SM, Clark JC, Crouzel C, Guillaume M, Helmeke HJ, Nebeling B, Pike VW, Stöcklin G (1993) PET radionuclide production. In: Stöcklin G, Pike VW (eds) Radio-pharmaceuticals for Positron Emission Tomography. Methodological Aspects. Kluwer Academic Publishers, pp 1–46
Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Folwer-Hoffman E, Alavi A, Som P, Sokoloff L (1979) The [18F]fluoro-deoxyglucose method for the measurement of local cerebral glucose utilization of man. Circ Res 44:127–137
Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, MacGregor RR, Shine CY, Atkins H, Anand A (1985) Glucose metabolic rate kinetic model$parameter determi-nation in humans: the lumped constants and rate constants for [18F] fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab 5:179–192
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J (1996) Oncological applications of positron emission tomography with fluorine-18fluorodeoxyglucose. Eur J Nucl Med 23:1641–1674
Schmidt KC, Lucignani G, Sokoloff L (1996) Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilisation: a re-examination. J Nucl Med 37:394–399
Snell AH (1937) A new radioisotope of fluorine. Phys Rev 51:143
Sokoloff L, Reivich M, Kennedy C, des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897–916
Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, Oster ZH, Sacker DF, Shiue CY, Turner H, Wan CN, Zabinski SV (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675
Tewson JT (1983) Synthesis of no-carrier-added fluorine-18 2-fluoro-2-deoxy-D-glucose. J Nucl Med 24:718–721
Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR (1990) Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol 17:273–279
Warburg O (1925) Über den Stoffwechsel der Carcinomzelle. Klin Wochenschr Berl 4:534–536
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hamkens, W., Rösch, F. (2000). FDG: biochemical concept and radiochemical synthesis. In: Wieler, H.J., Coleman, R.E. (eds) PET in Clinical Oncology. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57703-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-57703-1_6
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63329-4
Online ISBN: 978-3-642-57703-1
eBook Packages: Springer Book Archive